Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-10-19

Clinical Trial Update: Ceftriaxone in the Management of Bipolar Depression [NA]

View source ↗

Summary

Clinical trial update for ceftriaxone in bipolar depression; study terminated with results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ceftriaxone (ceftriaxone sodium)

Snippet

Sponsor: Yale University | Conditions: Bipolar Depression | NA | Status: TERMINATED | Results posted: 2016-10-19